Improving and Accelerating Therapeutic Development for Nervous System Disorders
Publisher: National Academies Press 2013
Number of pages: 116
The aim was to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline.
Home page url
Download or read it online for free here:
by Kenneth L Davis, at al. - Lippincott Williams & Wilkins
This book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders.
by Paul Heroux - Lulu.com
Contents: Scope of Toxicology; Risk Assessment; Targets and Bio-Transformation; Toxicokinetics; Hemato- and Vascular Toxicity; Dermatotoxicity; Neurotoxicity; Hepatotoxicity; Nephrotoxicity; Techniques In Vivo and In Vitro; Pulmonary Toxicity; etc.
by Anna Maria Geretti (ed.) - Mediscript
This book gives the reader insights into the more mechanistic aspects of resistance and the analyses behind the interpretation of resistance. The book provides a guide to those aspects of resistance that have the greatest impact on clinical care.
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.